Oragenics (OGEN) Asset Utilization Ratio (2011 - 2023)
Oragenics' (OGEN) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2023, down 29.22% YoY from 0.01 in Q4 2022, and up 27.19% on a QoQ basis from 0.0 in Q3 2023.
Oragenics (OGEN) Asset Utilization Ratio (2011 - 2023) Analysis & Trends
Oragenics (OGEN) has 7 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2023.
- Quarterly Asset Utilization Ratio fell 29.22% year-over-year to 0.01 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.01 (down 29.22% YoY) and the FY2023 annual result came in at 0.0, down 37.6% from the prior year.
- Asset Utilization Ratio improved to 0.01 in Q4 2023, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q2 2023 to a low of 0.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Sep 30, 2015 | 0.03 |
| Jun 30, 2015 | 0.05 |
| Mar 31, 2015 | 0.07 |
| Dec 31, 2014 | 0.08 |
| Sep 30, 2014 | 0.09 |
| Jun 30, 2014 | 0.08 |
| Mar 31, 2014 | 0.07 |
| Dec 31, 2013 | 0.08 |
| Sep 30, 2013 | 0.13 |
| Mar 31, 2012 | 0.92 |
| Dec 31, 2011 | 1.16 |
| Sep 30, 2011 | 1.06 |